Trial intelligence / Profile preview

Preoperative Antibiotics for UTI Prevention in Upper Tract Lithotomy

NCT02789579Phase 1Unknown

Sponsor
Xinhua Hospital
Start
Sep 2016
Primary completion
Dec 2019
Modality
Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 1, randomised, open-label trial of levofloxacin and nitrofurantoin in urinary tract infection (UTI) and sepsis (5 arms), sponsored by Xinhua Hospital. Primary endpoint: Urinary Tract Infection at 7 days. Status: unknown.

02

Drugs

levofloxacinnitrofurantoin
03

Conditions

urinary tract infection (UTI)sepsis

Beyond the preview

Go deeper on NCT02789579.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02789579.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call